Med-IQ Logo
Get CME/CE
E-Publication E-Publication

Patient-Clinician Perspectives on Insulin Therapy and the Role of Insulin Pens in Type 2 Diabetes: Current Evidence and Frontline Discussions


Insulin Pens
Time to complete:
60 Minutes
Released:
6/29/12
Expires:
6/28/13

Maximum Credits:

1.0 AMA PRA Category 1 Credit(s)
1.0 California Board of Registered Nursing (CBRN)
1.0 American Association of Diabetes Educators (AADE)

E-PublicationE-Publication
Time to complete:
60 Minutes

Released:
6/29/12

Expires:
6/28/13

Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
1.0 California Board of Registered Nursing (CBRN)
1.0 American Association of Diabetes Educators (AADE)
Share on:
E-PublicationE-Publication

Share on:


Time to complete:
60 Minutes
Released:
6/29/12
Expires:
6/28/13


Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
1.0 California Board of Registered Nursing (CBRN)
1.0 American Association of Diabetes Educators (AADE)


Overview: The American Association of Diabetes Educators (AADE) and Med-IQ are collaborating to offer this online text activity as part of a broad-reaching educational initiative to bring primary healthcare professionals and patients together for an exchange of perspectives on perceptions and barriers related to initiating insulin and using insulin pens in the management of type 2 diabetes. This activity is also designed to help formulate strategies to support the appropriate implementation of these devices into practice, foster effective communication to help overcome psychological insulin resistance, and reinforce patient and physician acceptance of this treatment modality.

As an extension of the live workshop series, this activity incorporates frontline perspectives and key teaching points from nationally recognized experts in diabetes, certified diabetes educators, and patients with diabetes.

Faculty

Timothy S. Reid, MD
Medical Director
Mercy Diabetes Center
Janesville, WI

Donna Rice, MBA, RN, CDE, FAADE
President, Big Picture Health, LLC
Past President, American Association of Diabetes Educators-2007
Chair, Education and Research Foundation, AADE
Dallas, TX


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Timothy S. Reid, MD
Consulting fees/advisory boards: Amylin Pharmaceuticals, Inc., Animas Corporation, Eli Lilly and Company, Medtronic, Inc., Novo Nordisk, sanofi-aventis U.S.
Fees received for promotional/non-CME activities: Amylin Pharmaceuticals, Inc., Animas Corporation, Eli Lilly and Company, Novo Nordisk, sanofi-aventis U.S.
 
Donna Rice, MBA, RN, CDE, FAADE
Consulting fees/advisory boards: Bayer HealthCare Pharmaceuticals, Inc., LifeScan, Inc., Novo Nordisk, sanofi-aventis U.S.
Contracted research: sanofi-aventis U.S.


The writer, Katherine Kahn, and activity planners, Robert Miller Geist IV and Lisa R. Rinehart, have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by an educational grant from Sanofi-aventis U.S. Inc., A SANOFI COMPANY.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

The following material has been developed to accompany this activity:

Understanding the Insulin Pen: An Educational Resource for People With Diabetes

Note: This material is not CME certified and, therefore, does not offer any CME/CE credit.

Play Video
The trifecta of healthcare improvement: value-based care, quality improvement, and technology.

See how Med-IQ is helping to enhance patient outcomes in these short videos.

Scott Weber, CEO Med-IQ

From Volume to Value-Based Care: The Role of the CME Enterprise

Scott Weber, CEO,
Med-IQ

Allison Gardner, PhD, VP Educational Strategy and Content, Med-IQ

The Value of Quality Improvement and Education to Advance Healthcare

Allison Gardner, PhD,
VP Educational Strategy and Content,
Med-IQ

Dr. Glenn Treisman,
Department of Psychiatry, Johns Hopkins Medical Institute

The Pros and Cons of Technology on the Practice of Medicine

Dr. Glenn Treisman,
Department of Psychiatry,
Johns Hopkins Medical Institute


Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.